Aurobindo Pharma reported INR53.22B in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Cipla INR 44.1B 5B Jun/2026
Divis Laboratories Ltd INR 19.61B 2.49B Jun/2026
Dr.Reddys Laboratories INR 41.78B 4.02B Jun/2026
Hindustan Unilever INR 84.31B 5.59B Jun/2026
Sun Pharmaceuticals INR 117.59B 7.65B Mar/2026
UPL INR 82.12B 26.16B Mar/2026